Literature DB >> 28338203

MiR-155 regulates oral squamous cell carcinoma Tca8113 cell proliferation, cycle, and apoptosis via regulating p27Kip1.

S Fu1, H-H Chen, P Cheng, C-B Zhang, Y Wu.   

Abstract

OBJECTIVE: P27Kip1 is the one of the negative regulators of the cell cycle that plays an important role in regulating cell cycle and inhibiting cell proliferation by restraining cell in G1 phase. P27Kip1 downregulation maybe related to the occurrence of oral squamous cell carcinoma (OSCC). It was found that miR-155 significantly upregulated in OSCC tissue. Bioinformatics analysis revealed that miR-155 may bind with the 3'-UTR of p27Kip1. This study investigated the role of miR-155 in regulating p27Kip1 and affecting Tca8113 cell proliferation, cycle, and apoptosis. PATIENTS AND METHODS: A total of 46 cases of OSCC patients received treatment in our hospital were enrolled to obtain tumor tissue. Another 25 normal oral mucosa samples were selected as control to detect the relationship between miR-155 and p27Kip1 expressions. Dual luciferase assay was adopted to confirm the targeted relationship between miR-155 and p27Kip1. Flow cytometry was applied to test cell apoptosis and cell cycle. CCK-8 assay was used to evaluate cell proliferation. Caspase-3 activity was detected by spectrophotometry.
RESULTS: MiR-155 upregulated, while p27Kip1 declined in OSCC tissue compared with normal oral mucosa. Their expressions were related to TNM stage. MiR-155 targeted suppressed p27Kip1 expression. MiR-155 mimic and/or pEGFP-p27Kip1 transfection obviously declined p27Kip1 expression, blocked cell cycle in G1 phase, reduced cell proliferation, enhanced Caspase-3 activity, and increased cell apoptosis in Tca8113 cells.
CONCLUSIONS: MiR-155 increased, while p27Kip1 reduced in OSCC tissue. Inhibition of miR-155 upregulated p27Kip1 expression, blocked cell cycle in G1 phase, weakened cell proliferation, and induced cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28338203

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  12 in total

1.  MicroRNA-155 expression is associated with pulpitis progression by targeting SHIP1.

Authors:  Baishun Li; Liyang Guo; Ying He; Xinran Tu; Jialin Zhong; Hongbing Guan; Yiguo Jiang; Qianzhou Jiang
Journal:  Mol Biol Rep       Date:  2022-07-14       Impact factor: 2.742

2.  MicroRNA‑198 suppresses tumour growth and metastasis in oral squamous cell carcinoma by targeting CDK4.

Authors:  Yuanyuan Kang; Ying Zhang; Yan Sun
Journal:  Int J Oncol       Date:  2021-05-13       Impact factor: 5.650

3.  Long non-coding RNA BBOX1-antisense RNA 1 enhances cell proliferation and migration and suppresses apoptosis in oral squamous cell carcinoma via the miR-3940-3p/laminin subunit gamma 2 axis.

Authors:  Chunguang Zhao; Wei Shi; Min Chen
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 4.  Emerging insights into the biology of metastasis: A review article.

Authors:  Soussan Irani
Journal:  Iran J Basic Med Sci       Date:  2019-08       Impact factor: 2.699

5.  microRNA-155 Modulates Hepatic Stellate Cell Proliferation, Apoptosis, and Cell Cycle Progression in Rats With Alcoholic Hepatitis via the MAPK Signaling Pathway Through Targeting SOCS1.

Authors:  Dengtao Liu; Ping Han; Chunhai Gao; Wei Gao; Xiaocui Yao; Shulan Liu
Journal:  Front Pharmacol       Date:  2020-04-07       Impact factor: 5.810

Review 6.  Prospective applications of microRNAs in oral cancer.

Authors:  Chuan Fang; Yadong Li
Journal:  Oncol Lett       Date:  2019-08-16       Impact factor: 2.967

7.  Evidence That Regulation of Pri-miRNA/miRNA Expression Is Not a General Rule of miPEPs Function in Humans.

Authors:  Anne Prel; Christine Dozier; Jean-Philippe Combier; Serge Plaza; Arnaud Besson
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

8.  Differential MicroRNA Expression of miR-21 and miR-155 within Oral Cancer Extracellular Vesicles in Response to Melatonin.

Authors:  Matthew Hunsaker; Greta Barba; Karl Kingsley; Katherine M Howard
Journal:  Dent J (Basel)       Date:  2019-05-01

9.  MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1.

Authors:  Wei Zhang; Wenyue Ji; Xudong Zhao
Journal:  BMC Cancer       Date:  2019-11-12       Impact factor: 4.430

Review 10.  MicroRNAs as Modulators of Oral Tumorigenesis-A Focused Review.

Authors:  Kumar Rishabh; Soham Khadilkar; Aviral Kumar; Ishu Kalra; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.